NPI 1467516757: Open Payments
NPI 1467516757. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$133 in 6 payments from 5 companies in 2025. Trend: 2023 $232 · 2024 $409 · 2025 $133
Food & beverage: $133
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $45 |
| Smith+Nephew, Inc. | 1 | $24 |
| Verona Pharma, Inc. | 1 | $23 |
| Novo Nordisk Inc | 1 | $22 |
| Exact Sciences Corporation | 1 | $19 |
Products named: MOUNJARO, RENASYS TOUCH, Ohtuvayre, Ozempic, Cologuard Collection Kit.
